RECLI FEDERICO SEGHI enters TITAN PHARMACEUTICALS INC with 100.84K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/23/2018ACC: 0001144204-18-030506
Director
Since Sep 2018
100.84K
Baseline shares
100% direct
100.84K
Direct ownership
1 position
2.54M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned100.84K
Total
100.84K direct100.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100.84K | Direct |
| Total | 100.84K | 100.84K direct |
Derivative Holdings3
Warrant (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
540K
Shares owned
N/A
Exercise price
1.20
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
5K
Shares owned
N/A
Exercise price
0.84
Expiration
—
Exercise window
—
Convertible Note
IndirectUnderlying security
Common Stock
Underlying shares
2M
Shares owned
N/A
Exercise price
1.20
Expiration
—
Exercise window
—
Total
Underlying
2.54M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant (Right to Buy) Indirect | Common Stock | 1.20 | — | — | 540K | N/A |
| Option (Right to Buy) Direct | Common Stock | 0.84 | — | — | 5K | N/A |
| Convertible Note Indirect | Common Stock | 1.20 | — | — | 2M | N/A |
| Total | 2.54M | 0.00 | ||||